000 01426 a2200349 4500
005 20250518020152.0
264 0 _c20190314
008 201903s 0 0 eng d
022 _a1129-2377
024 7 _a10.1186/s10194-018-0955-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSacco, Simona
245 0 0 _aEuropean headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention.
_h[electronic resource]
260 _bThe journal of headache and pain
_cJan 2019
300 _a6 p.
_bdigital
500 _aPublication Type: Journal Article; Practice Guideline; Systematic Review
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aCalcitonin Gene-Related Peptide
_xantagonists & inhibitors
650 0 4 _aCalcitonin Gene-Related Peptide Receptor Antagonists
_xtherapeutic use
650 0 4 _aHeadache
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMigraine Disorders
_xdrug therapy
700 1 _aBendtsen, Lars
700 1 _aAshina, Messoud
700 1 _aReuter, Uwe
700 1 _aTerwindt, Gisela
700 1 _aMitsikostas, Dimos-Dimitrios
700 1 _aMartelletti, Paolo
773 0 _tThe journal of headache and pain
_gvol. 20
_gno. 1
_gp. 6
856 4 0 _uhttps://doi.org/10.1186/s10194-018-0955-y
_zAvailable from publisher's website
999 _c29261937
_d29261937